文献速递系统性红斑狼疮

新的EULAR/ACR 2019系统性红斑狼疮分类标准:长期结局的预测因素

The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes.
PubMed 文献 · Semin Arthritis Rheum · 2022-09-25

研究纳入多伦多狼疮诊所诊断后12个月内就诊的867例起始系统性红斑狼疮患者,基于基线临床和实验室信息计算EULAR/ACR评分,以20分为阈值比较结局。评分≥20组诊断后前10年累积损伤更多(210例[46%] vs 167例[40%],P=0.02),多变量回归HR 1.34(P=0.007),死亡风险更高(HR 2.34,P=0.001);排除基线肾脏受累患者后,高评分组损伤累积风险仍更高(HR 1.46,P=0.006),但两组死亡率无差异(P=0.54)。

要点

  • 基线EULAR/ACR评分≥20与诊断后前10年更多损伤累积相关(46% vs 40%,P=0.02)。
  • 基线EULAR/ACR评分≥20与更高死亡风险相关(HR 2.34,P=0.001)。
  • 排除基线肾脏受累者后,高评分组损伤累积风险仍更高(HR 1.46,P=0.006),死亡率无差异(P=0.54)。

核心结论

  • 基线EULAR/ACR评分≥20是长期结局的指标,尤其是损伤累积。

研究设计与样本

  • 纳入多伦多狼疮诊所诊断后12个月内就诊的起始系统性红斑狼疮患者,共867例。
  • 基于基线临床和实验室信息计算EULAR/ACR评分,以20分为阈值分组(<20 vs ≥20),阈值依据受试者工作特征分析确定。

主要发现

  • 诊断后前10年,评分≥20组累积损伤210例(46%),评分<20组167例(40%),P=0.02。
  • 多变量回归分析显示评分≥20与损伤累积相关(HR 1.34,P=0.007)。
  • 评分≥20组死亡风险更高(HR 2.34,P=0.001)。
  • 排除基线肾脏受累患者后,评分≥20组损伤累积风险仍更高(HR 1.46,P=0.006),但两组死亡率无差异(P=0.54)。

关键数值与推荐

  • EULAR/ACR评分≥20为阈值,用于比较长期结局。
  • 评分≥20组 vs <20组前10年损伤累积:210例(46%) vs 167例(40%),P=0.02。
  • 评分≥20组损伤累积HR 1.34(P=0.007),死亡HR 2.34(P=0.001)。
  • 排除基线肾脏受累者后,评分≥20组损伤累积HR 1.46(P=0.006),死亡率组间P=0.54。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the ability of a EULAR/ACR SLE criteria score ≥20 to predict damage accrual and mortality. METHODS: Inception SLE patients from the Toronto Lupus Clinic recruited in the first 12 months after diagnosis were included. A EULAR/ACR criteria score was calculated based on the baseline clinical and laboratory information. A EULAR/ACR score of 20 was used as a threshold to compare outcomes between groups (EULAR/ACR score <20 vs ≥20), based on receiver operating characteristic analysis. RESULTS: 867 SLE patients were included. The group of patients with the higher score accrued more damage compared to the group with the lower score in the first 10 years after diagnosis (210 [46%] vs 167 [40%] for patients with a score ≥20 vs < 20 respectively p = 0.02). This was corroborated by multivariable regression analysis (HR 1.34, p = 0.007). Patients with a score of ≥20 had a higher risk of death (HR 2.34, p = 0.001). When excluding patients who had kidney involvement at baseline, the group with the higher score continued to be at a higher risk of damage accrued (HR 1.46, p = 0.006), although there was no difference in mortality between groups (p = 0.54). CONCLUSION: A EULAR/ACR criteria score ≥20 at baseline is an indicator of long-term outcomes, especially damage accrual.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Whittall-Garcia L, Gladman DD, Urowitz MB, et al. The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomes. Semin Arthritis Rheum. 2022. PMID: 36219896. doi:10.1016/j.semarthrit.2022.152103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。